- Home
- ESPR vs ALLT Comparison
ESPR vs ALLT Comparison
Compare ESPR & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- ALLT
- Stock Information
- Founded
- ESPR 2008
- ALLT 1996
- Country
- ESPR United States
- ALLT Israel
- Employees
- ESPR N/A
- ALLT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- ALLT Telecommunications Equipment
- Sector
- ESPR Health Care
- ALLT Telecommunications
- Exchange
- ESPR Nasdaq
- ALLT Nasdaq
- Market Cap
- ESPR 534.3M
- ALLT 458.2M
- IPO Year
- ESPR 2013
- ALLT 2006
- Fundamental
- Price
- ESPR $2.97
- ALLT $9.63
- Analyst Decision
- ESPR Buy
- ALLT Strong Buy
- Analyst Count
- ESPR 6
- ALLT 3
- Target Price
- ESPR $6.50
- ALLT $12.75
- AVG Volume (30 Days)
- ESPR 7.1M
- ALLT 357.5K
- Earning Date
- ESPR 11-06-2025
- ALLT 11-18-2025
- Dividend Yield
- ESPR N/A
- ALLT N/A
- EPS Growth
- ESPR N/A
- ALLT N/A
- EPS
- ESPR N/A
- ALLT N/A
- Revenue
- ESPR $268,125,000.00
- ALLT $95,342,000.00
- Revenue This Year
- ESPR $18.83
- ALLT $10.44
- Revenue Next Year
- ESPR N/A
- ALLT $12.99
- P/E Ratio
- ESPR N/A
- ALLT N/A
- Revenue Growth
- ESPR N/A
- ALLT 4.74
- 52 Week Low
- ESPR $0.69
- ALLT $3.35
- 52 Week High
- ESPR $3.94
- ALLT $11.42
- Technical
- Relative Strength Index (RSI)
- ESPR 59.21
- ALLT 46.63
- Support Level
- ESPR $2.80
- ALLT $9.54
- Resistance Level
- ESPR $3.11
- ALLT $10.69
- Average True Range (ATR)
- ESPR 0.17
- ALLT 0.46
- MACD
- ESPR 0.01
- ALLT -0.09
- Stochastic Oscillator
- ESPR 76.47
- ALLT 30.07
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.